Hispidulin: a potential alternative to vorinostat against HDAC1 for acute myeloid leukemia
Abstract Acute myeloid leukemia (AML) has a survival rate of only 30%, predominantly affecting the bone marrow. AML is characterized by failure of bone marrow function to produce healthy blood cells resulting in significant clinical symptoms such as anemia, shortness of breath, and paleness of skin....
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-07-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-03182-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|